Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage

Mucosal Immunology

Volumn 7, Issue 3, 2014, Pages 705-717

  Gray, C ^a   Ahmed, M S ^a   Mubarak, A ^a   Kasbekar, A V ^b   Derbyshire, S ^b   McCormick, M S ^c   Mughal, M K ^d   McNamara, P S ^a   Mitchell, T ^e   Zhang, ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; PNEUMOLYSIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL PROTEIN; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; STREPTOLYSIN;

ANIMAL CELL; ARTICLE; BACTERIUM CARRIER; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION PREVENTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MACROPHAGE; MEMORY T LYMPHOCYTE; MONOCYTE; MOUSE; NASOPHARYNX ASSOCIATED LYMPHOID TISSUE; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; TH17 CELL; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; HETEROZYGOTE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MICROBIOLOGY; NASOPHARYNX; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTERIAL PROTEINS; CARRIER STATE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MACROPHAGES; MALE; MICE; MONOCYTES; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS; TH17 CELLS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899577334     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.89     Document Type: Article

References (53)

1. Siber, G.R. Pneumococcal disease: prospects for a new generation of vaccines. Science 265, 1385-1387 (1994).
2. Peltola, H. Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clin. Infect. Dis. 32, 64-75 (2001).
3. Weinberger,D.M., Malley,R& Lipsitch, M. Serotype replacement in disease after pneumococcal vaccination. Lancet 378, 1962-1973 (2011).
4. Spratt, B.G. & Greenwood, B.M. Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 356, 1210-1211 (2000).
5. Paton, J.C. Novel pneumococcal surface proteins: role in virulence and vaccine potential. Trends Microbiol. 6, 85-87 (1998).
6. Lipsitch, M, Whitney, C.G., Zell, E, Kaijalainen, T, Dagan, R & Malley, R. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?. PLoS Med. 2, e15 (2005).
7. Kadioglu, A, Gingles, N.A.,Grattan, K, Kerr, A,Mitchell, T.J. & Andrew, P.W. Host cellular immune response to pneumococcal lung infection in mice. Infect. Immun. 68, 492-501 (2000).
8. Kadioglu, A, Coward, W, Colston, M.J., Hewitt, C.R. & Andrew, P.W. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect. Immun. 72, 2689-2697 (2004).
9. Malley, R, Trzcinski, K, Srivastava, A, Thompson, C.M., Anderson, P.W. & Lipsitch, M. CD4 T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc. Natl. Acad. Sci. USA 102, 4848-4853 (2005).
10. Lu, Y.J. et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4, e1000159 (2008).
11. Zhang, Z, Clarke, T.B. & Weiser, J.N. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization inmice. J. Clin. Invest. 119, 1899-1909 (2009).
12. O'Connor,W, Zenewicz, L.A. & Flavell, R.A. The dual nature of TH17 cells: shifting the focus to function. Nat. Immunol. 11, 471-476 (2010).
13. Curtis, M.M. & Way, S.S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126, 177-185 (2009).
14. Milner, J.D. et al. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452, 773-776 (2008).
15. Kiyono, H, Fukuyama, S, Kiyono, H & Fukuyama, S. NALT-versus Peyer'spatch-mediated mucosal immunity. [Review; 102 refs]. Nat. Rev. Immunol. 4, 699-710 (2004).
16. Bernstein, J.M., Gorfien, J & Brandtzaeg, P. The immunobiology of the tonsils and adenoids. In: Ogra P.L., Mestecky J, Lamm M.E., Strober W., McGhee J.R., & Bienenstock J, (eds). Mucosal Immunology. Academic Press, San Diego, pp 1339-1362 (1999).
17. Mattila, P.S., Hammarén-Malmi, S, Saxen, H, Kaijalainen, T, Käyhty, H & Tarkkanen, J. Adenoidectomy and nasopharyngeal carriage of Streptococcus pneumoniae in young children. Arch. Dis. Child. 95, 696-702 (2010).
18. Mattila, P.S., Hammarén-Malmi, S, Saxen, H, Kaijalainen, T, Käyhty, H & Tarkkanen, J. Adenoidectomy in young children and serum IgG antibodies to pneumococcal surface protein A and choline binding protein A. Int. J. Pediatr. Otorhinolaryngol. 76, 1569-1574 (2012).
19. Zhang, Q, Choo, S & Finn, A. Immune responses to novel pneumococcal proteins (Pneumolysin, PspA, PsaA and CbpA) in adenoidal B cells from children. Infect. Immun. 70, 5363-5369 (2002).
20. Zhang, Q. et al. Bacterial lipoproteins differentially regulate human primary and memory CD4+ T and B cell responses to pneumococcal protein antigens through Toll-like receptor 2. J. Infect. Dis. 201, 1753-1763 (2010).
21. Berry, A.M., Alexander, J.E., Mitchell, T.J., Andrew, P.W., Hansman, D & Paton, J.C. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect. Immun. 63, 1969-1974 (1995).
22. Alexander, J.E. et al. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia. Microb. Pathog. 24, 167-174 (1998).
23. Ogunniyi, A.D., Woodrow, M.C., Poolman, J.T. & Paton, J.C. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect. Immun. 69, 5997-6003 (2001).
24. Kirkham, L.A. et al. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect. Immun. 74, 586-593 (2006).
25. Zhang,Q. et al. Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status. Eur. J. Immunol. 36, 46-57 (2006).
26. Zhang, Q. et al. Low CD4 Tcell immunity to pneumolysin is associatedwith nasopharyngeal carriage of pneumococci in children. J. Infect. Dis. 195, 1194-1202 (2007).
27. Baba, H. et al. Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins. Biochem. Biophys. Res. Commun. 281, 37-44 (2001).
28. Yang, L. et al. IL-21 and TGF-[bgr] are required for differentiation of human TH17 cells. Nature 454, 350-352 (2008).
29. Louten, J, Boniface, K & deWaal Malefyt, R. Development and function of TH17 cells in health and disease. J. Allergy Clin. Immunol. 123, 1004-1011 (2009).
30. Olliver, M, Hiew, J, Mellroth, P, Henriques-Normark, B & Bergman, P. Human monocytes promote Th1 and Th17 responses to Streptococcus pneumoniae. Infect. Immun. 79, 4210-4217 (2011).
31. Lundgren, A. et al. Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country. Vaccine 30, 3897-3907 (2012).
32. Khader, S.A., Gaffen, S.L. & Kolls, J.K. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol. 2, 403-411 (2009).
33. Dubin, P.J. & Kolls, J.K. Th17 cytokines and mucosal immunity. Immunol. Rev. 226, 160-171 (2008).
34. Acosta-Rodriguez, E.V. et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639-646 (2007).
35. Lin, Y, Slight, S & Khader, S. Th17 cytokines and vaccine-induced immunity. Semin. Immunopathol. 32, 79-90 (2010).
36. Chen, K. et al. Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity 35, 997-1009 (2011).
37. Happel, K.I. et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202, 761-769 (2005).
38. Kolls, J.K. & Lindén, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
39. Cecchinato, V. et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virusinfected macaques. Mucosal. Immunol. 1, 279-288 (2008).
40. Aujla, S.J., Dubin, P.J. & Kolls, J.K. Th17 cells and mucosal host defense. Semin. Immunol. 19, 377-382 (2007).
41. Wright, A.K.A. et al. Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLoS Pathog. 9, e1003274 (2013).
42. Zhang, Q, Leong, S.C., McNamara, P.S., Mubarak, A, Malley, R & Finn, A. Characterisation of regulatory Tcells in nasal associated lymphoid tissue in children: relationships with pneumococcal colonization. PLoS Pathog. 7, e1002175 (2011).
43. Malley, R & Anderson, P.W. Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc. Natl. Acad Sci. USA 109, 3623-3627 (2012).
44. Malley, R. et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad Sci. USA 100, 1966-1971 (2003).
45. McNeela, E.A. et al. Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog. 6, e1001191 (2010).
46. Witzenrath,M. et al. The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J. Immunol. 187, 434-440 (2011).
47. Belyakov, I.M. & Ahlers, J.D. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?. J. Immunol. 183, 6883-6892 (2009).
48. Moffitt, K.L. et al. TH17-based vaccine design for prevention of streptococcus pneumoniae colonization. Cell Host Microbe 9, 158-165 (2011).
49. Moffitt, K.L., Malley, R & Lu, Y.-J. Identification of protective pneumococcal TH17 antigens from the soluble fraction of a killed whole cell vaccine. PLoS One 7, e43445 (2012).
50. O'Brien, K.L. & Nohynek, H. Report from aWHOWorkingGroup: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr. Infect. Dis. J. 22, e1-11 (2003).
51. Zhang, Q, Choo, S & Finn, A. Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children. Infect. Immun. 70, 5363-5369 (2002).
52. Farrand, A.J., LaChapelle, S, Hotze, E.M., Johnson, A.E. & Tweten, R.K. Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc. Natl. Acad Sci. USA 107, 4341-4346 (2010).
53. Benton, K.A., Paton, J.C. & Briles, D.E. Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production. Infect. Immun. 65, 1237-1244 (1997).